INSIGHTS ON QUALITY CONTROL

• Ensuring Consistent Quality In Pharmaceutical Water For Injection (WFI) Systems Presentation

  Maintaining high-purity water is vital for pharmaceutical production. Explore key strategies for system design, risk mitigation, and rigorous process control to ensure consistent regulatory compliance.

• The Confidence To Go Faster: A Playbook For Digital Lab Operations

  Bridge the gap between lab speed and scientific confidence. Learn to eliminate operational bottlenecks, ensure material readiness, and create the traceable data needed for an AI-ready future.

• Which X-Ray, Metal Detector, Or Checkweigher Is Right For Your Industry?

  Navigate the complexities of pharmaceutical safety with a guide to tailored inspection systems. Match the right technology to your specific product format for total compliance and quality.

• Method Migration Of A Normal Phase HPLC Method For Tocopherols

  The ability to migrate methods across HPLC systems is essential as systems are updated. Review a normal phase method that provides a means for quantification of tocopherols in vitamin supplements.

• Doubling Up For Speed In Biomanufacturing

  12/12/2025

  Accelerate drug development and reduce risk with parallel operations. Learn how leveraging CDMO partnerships while building internal capabilities can cut costs and speed your path to market.

• CMO Validation As A Service

  8/20/2024

  Learn about the highly successful commissioning and qualification of Wheeler's Oklahoma City CDMO facility with the overarching goal of ensuring all equipment was qualified for a Phase 3 clinical production campaign.

• The Seamless Path To Market: End-To-End CDMOs As Your Strategic Ally Douglas CDMO

  5/14/2025

  Partner with an experienced end-to-end CDMO to streamline development, reduce risk, and accelerate your drug’s path to market in today’s complex and competitive pharmaceutical landscape.

• Accelerate Biologics Product Release With Seamless Viral Testing

  6/23/2025

  Explore viral safety testing for biologics, focusing on prevention, detection, and removal strategies, updated regulatory guidance, and common challenges in unprocessed bulk testing.

• What Pharmacies Often Miss In USP <800> Compliance

  5/27/2026

  Master USP <800> compliance by transitioning from standalone equipment to an integrated system design. Review key protocols for a multi-layered strategy to mitigate cumulative drug risks.